These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28270032)

  • 1. Development of oxidovanadium and oxido-peroxido vanadium-based artificial DNA nucleases via multi spectroscopic investigations and theoretical simulation of DNA binding.
    Palmajumder E; Sepay N; Mukherjea KK
    J Biomol Struct Dyn; 2018 Mar; 36(4):919-927. PubMed ID: 28270032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship on DNA binding and anticancer activities of a family of mixed-ligand oxidovanadium(V) hydrazone complexes.
    Patra D; Paul S; Sepay N; Kundu R; Ghosh T
    J Biomol Struct Dyn; 2018 Dec; 36(16):4143-4155. PubMed ID: 29171343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cu(II) and Mn(II) complexes containing macroacyclic ligand: synthesis, DNA binding, and cleavage studies.
    Sreekanth B; Krishnamurthy G; Naik HS; Vishnuvardhan TK
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(1):1-13. PubMed ID: 22257206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental and theoretical investigations of novel oxidovanadium(IV) juglone complex: DNA/HSA interaction and cytotoxic activity.
    Abyar F; Tabrizi L
    J Biomol Struct Dyn; 2020 Feb; 38(2):474-487. PubMed ID: 30831056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of DNA/BSA interaction and catalytic potential of oxidovanadium(v) complexes with ONO donor ligands.
    Dash SP; Panda AK; Dhaka S; Pasayat S; Biswas A; Maurya MR; Majhi PK; Crochet A; Dinda R
    Dalton Trans; 2016 Nov; 45(45):18292-18307. PubMed ID: 27805190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
    Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
    J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, reactivity and catalytic activity of oxidovanadium(IV), oxidovanadium(V) and dioxidovanadium(V) complexes of benzimidazole modified ligands.
    Maurya MR; Bisht M; Kumar A; Kuznetsov ML; Avecilla F; Pessoa JC
    Dalton Trans; 2011 Jul; 40(26):6968-83. PubMed ID: 21647507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and structural investigation of some alkali metal ion-mediated LV(V)O2(-) (L(2-) = tridentate ONO ligands) species: DNA binding, photo-induced DNA cleavage and cytotoxic activities.
    Dash SP; Panda AK; Pasayat S; Dinda R; Biswas A; Tiekink ER; Patil YP; Nethaji M; Kaminsky W; Mukhopadhyay S; Bhutia SK
    Dalton Trans; 2014 Jul; 43(26):10139-56. PubMed ID: 24874519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.
    Roy S; Böhme M; Dash SP; Mohanty M; Buchholz A; Plass W; Majumder S; Kulanthaivel S; Banerjee I; Reuter H; Kaminsky W; Dinda R
    Inorg Chem; 2018 May; 57(10):5767-5781. PubMed ID: 29741373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined experimental and theoretical investigation of ruthenium(II)-hydrazone complex with DNA: Spectroscopic, nuclease activity, topoisomerase inhibition and molecular docking.
    Gaur R; Usman M
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Feb; 209():100-108. PubMed ID: 30384015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the effect of substituent in the hydrazone ligand of a family of μ-oxidodivanadium(v) hydrazone complexes on structure, DNA binding and anticancer activity.
    Patra D; Paul S; Majumder I; Sepay N; Bera S; Kundu R; Drew MGB; Ghosh T
    Dalton Trans; 2017 Nov; 46(46):16276-16293. PubMed ID: 29138774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatise on benzimidazole based Schiff base metal(II) complexes accentuating their biological efficacy: Spectroscopic evaluation of DNA interactions, DNA cleavage and antimicrobial screening.
    Kumaravel G; Raman N
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):184-194. PubMed ID: 27770880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding and cleavage studies of copper(II) complexes with 2'-deoxyadenosine modified histidine moiety.
    Borowska J; Sierant M; Sochacka E; Sanna D; Lodyga-Chruscinska E
    J Biol Inorg Chem; 2015 Sep; 20(6):989-1004. PubMed ID: 26186904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
    Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
    J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations.
    Sciortino G; Sanna D; Ugone V; Micera G; Lledós A; Maréchal JD; Garribba E
    Inorg Chem; 2017 Nov; 56(21):12938-12951. PubMed ID: 28985059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, DNA binding, and cleavage studies of Co(III) complexes with fused aromatic NO/NN-containing ligands.
    Sudhamani CN; Bhojya Naik HS; Girija D
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(2):130-46. PubMed ID: 22303992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal complex interactions with DNA.
    Pages BJ; Ang DL; Wright EP; Aldrich-Wright JR
    Dalton Trans; 2015 Feb; 44(8):3505-26. PubMed ID: 25427534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding and nuclease activity of an oxovanadium valinato-Schiff base complex.
    Saha U; Mukherjea KK
    Int J Biol Macromol; 2014 May; 66():166-71. PubMed ID: 24560950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
    Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
    Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Vanadium(V) complexes derived from pyridoxal/salicylaldehyde. Interaction with CT-DNA/HSA, and molecular docking assessments.
    Fioravanço LP; Pôrto JB; Martins FM; Siqueira JD; Iglesias BA; Rodrigues BM; Chaves OA; Back DF
    J Inorg Biochem; 2023 Feb; 239():112070. PubMed ID: 36450221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.